Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia

Por Shahrzad Bakhtiar, Sandra Woelke, Sabine Huenecke, Matthias Kieslich, Alexander Malcolm Taylor, Ralf Schubert, Stefan Zielen, Peter Bader
Publicado em 2018-10-01

The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases

Por Zyrafete Kuҫi, Christiane Jordan, Sibylle Wehner, Jan Sörensen, Andrea Jarisch, Emilia Salzmann-Manrique, Lisa-Marie Pfeffermann, Thomas Klingebiel, Peter Bader, Selim Kuҫi
Publicado em 2020-02-01

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

Por Juliane Wagner, Juliane Wagner, Juliane Wagner, Viktoria Pfannenstiel, Viktoria Pfannenstiel, Viktoria Pfannenstiel, Anja Waldmann, Judith W. J. Bergs, Judith W. J. Bergs, Judith W. J. Bergs, Boris Brill, Sabine Huenecke, Sabine Huenecke, Thomas Klingebiel, Franz Rödel, Franz Rödel, Franz Rödel, Christian J. Buchholz, Christian J. Buchholz, Christian J. Buchholz, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Peter Bader, Peter Bader, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich
Publicado em 2017-06-01

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Ca...

Por Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, Hendrik Gassmann, Carolin Prexler, Angela Wawer, Irene von Luettichau, Ruth Ladenstein, Bernarda Kazanowska, Gustaf Ljungman, Felix Niggli, Olli Lohi, Julia Hauer, Bernd Gruhn, Thomas Klingebiel, Peter Bader, Stefan Burdach, Peter Lang, Monika Sparber-Sauer, Monika Sparber-Sauer, Ewa Koscielniak, Ewa Koscielniak, Uwe Thiel
Publicado em 2022-05-01